icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Barcelona, Spain
13-17 April 2016
Back grey_arrow_rt.gif
 
 
 
Resistance Analyses for Ledipasvir/Sofosbuvir-Containing Regimens in Patients Infected With Chronic HCV Who Have Advanced Liver Disease Or Are Post Liver Transplant (SOLAR-1 and -2 Studies)
 
 
  Reported by Jules Levin
EASL 2026 April 14-17 Barcelona
 
Michael Charlton1, Michael Manns2, Hadas Dvory-Sobol3, Evguenia Svarovskaia3, Brian Doehle3, Sarah Arterburn3, Shampa De-Oertel3, Diana M. Brainard3, John G. McHutchison3, Michael D. Miller3, Hongmei Mo3, Nezam Afdhal4, David Mutimer5
1Intermountain Medical Center, Murray, Utah, USA; 2Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; 3Gilead Sciences, Inc., Foster City, California, USA; 4Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; 5NIHR Liver Biomedical Research Unit, Queen Elizabeth Hospital, Birmingham, UK

EASL1

EASL2

EASL3

EASL4

EASL5

EASL6

EASL7

EASL8